Cobalt therapy

Last updated

Cobalt therapy
Nci-vol-1819-300 cobalt 60 therapy.jpg
Other namesCobalt-60 therapy
Specialty oncology

Cobalt therapy is the medical use of gamma rays from the radioisotope cobalt-60 to treat conditions such as cancer. Beginning in the 1950s, cobalt-60 was widely used in external beam radiotherapy (teletherapy) machines, which produced a beam of gamma rays which was directed into the patient's body to kill tumor tissue. Because these "cobalt machines" were expensive and required specialist support, they were often housed in cobalt units. Cobalt therapy was a revolutionary advance in radiotherapy in the post-World War II period but is now being replaced by other technologies such as linear accelerators.

Contents

History

Before the development of medical linear accelerators in the 1970s, the only artificial radiation source used for teletherapy was the x-ray tube. Researchers found ordinary x-ray tubes, which used voltages of 50-150 keV, could treat superficial tumors, but did not have the energy to reach tumors deep in the body. To have the penetrating ability to reach deep-seated tumors without subjecting healthy tissue to dangerous radiation doses required rays with energy around a million electron volts (MeV), called "megavoltage" radiation. To produce a significant amount of MeV x-rays required potentials on the tube of 3-5 million volts (3-5 megavolts), necessitating huge, expensive x-ray machines. By the late 1930s these were being built, but they were available at only a few hospitals.

The first cobalt machine in Italy, installed in Borgo Valsugana in 1953. Eldorado A.jpeg
The first cobalt machine in Italy, installed in Borgo Valsugana in 1953.

Radioisotopes produced gamma rays in the megavolt range, but prior to World War II virtually the only radioisotope available for radiotherapy was naturally occurring radium (producing 1-2 MeV gamma rays), which was extremely expensive due to its low occurrence in ores. In 1937 the price of radium US$25,000(equivalent to $508,912 in 2022) per gram, [1] and the total worldwide supply of radium available for beam radiotherapy (teletherapy) was 50 grams.

The invention of the nuclear reactor in the Manhattan Project during World War II made possible the creation of artificial radioisotopes for radiotherapy. Cobalt-60, produced by neutron irradiation of ordinary cobalt metal in a reactor, is a high activity gamma-ray emitter, emitting 1.17 and 1.33 MeV gamma rays with an activity of 44  TBq / g (1,200  Ci /g). The main reason for its wide use in radiotherapy is that it has a longer half-life, 5.27 years, than many other gamma emitters. However, this half-life still requires cobalt sources to be replaced about every 5 years.

In 1949, Dr. Harold E. Johns of the University of Saskatchewan sent a request to the National Research Council (NRC) of Canada asking it to produce cobalt-60 isotopes for use in a cobalt therapy unit prototype. Two cobalt-60 apparatuses were then built, one in Saskatoon in the cancer wing of the University of Saskatchewan and the other in London, Ontario. Johns collected depth-dose data at the University of Saskatchewan which would later become the world standard. [2] The first patient to be treated with cobalt-60 radiation was treated on October 27, 1951, at the War Memorial Children's Hospital in London, Ontario. [3] [4] In 1961 cobalt therapy was expected to replace X-ray radiotherapy. [5] :14 In 1966, Walt Disney's lung cancer was treated with this procedure, but could not prevent his death. [6]

Dr. Glenn T. Seaborg, chairman of the United States Atomic Energy Commission, Nobel Prize winner and former chancellor of the University of California, dedicated the first cobalt facility of the new Radiation Therapy and Nuclear Medicine Wing of the Cedars of Lebanon Hospital on January 11, 1963 supervised by Dr. Henry L. Jaffe, Director of the new department. A pioneer in the use of the nicknamed "cobalt bomb" the Cedars unit was licensed in 1948 by the Atomic Energy Commission. [7]

Current use

The role of the cobalt unit has partly been replaced by the linear accelerator, which can generate higher-energy radiation, and does not produce the radioactive waste that radioisotopes do with their attendant disposal problems. Cobalt treatment still has a useful role to play in certain applications and is still in widespread use worldwide, since the machinery is relatively reliable and simple to maintain compared to the modern linear accelerator.

Isotope

As used in radiotherapy, cobalt units produce stable, dichromatic beams of 1.17 and 1.33 MeV, resulting in an average beam energy of 1.25 MeV. Cobalt-60 has a half-life of 5.2713 years. [8] :39

See also

Related Research Articles

<span class="mw-page-title-main">Radiation therapy</span> Therapy using ionizing radiation, usually to treat cancer

Radiation therapy or radiotherapy, often abbreviated RT, RTx, or XRT, is a therapy using ionizing radiation, generally provided as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor. Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. A physician who practices in this subspecialty is a radiation oncologist.

<span class="mw-page-title-main">External beam radiotherapy</span> Treatment of cancer with ionized radiation

External beam radiation therapy (EBRT) describes the use of a collimated beam of ionizing radiation from outside the body to treat a disease. As follows:

Radionuclide therapy uses radioactive substances called radiopharmaceuticals to treat medical conditions, particularly cancer. These are introduced into the body by various means and localise to specific locations, organs or tissues depending on their properties and administration routes. This includes anything from a simple compound such as sodium iodide that locates to the thyroid via trapping the iodide ion, to complex biopharmaceuticals such as recombinant antibodies which are attached to radionuclides and seek out specific antigens on cell surfaces.

<span class="mw-page-title-main">Megavoltage X-rays</span> High energy (>1MeV) X-rays

Megavoltage X-rays are produced by linear accelerators ("linacs") operating at voltages in excess of 1000 kV (1 MV) range, and therefore have an energy in the MeV range. The voltage in this case refers to the voltage used to accelerate electrons in the linear accelerator and indicates the maximum possible energy of the photons which are subsequently produced. They are used in medicine in external beam radiotherapy to treat neoplasms, cancer and tumors. Beams with the voltage range of 4-25 MV are used to treat deeply buried cancers because radiation oncologists find that they penetrate well to deep sites within the body. Lower energy x-rays, called orthovoltage X-rays, are used to treat cancers closer to the surface.

<span class="mw-page-title-main">Proton therapy</span> Medical Procedure

In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.

<span class="mw-page-title-main">Radiosurgery</span> Surgical Specialty

Radiosurgery is surgery using radiation, that is, the destruction of precisely selected areas of tissue using ionizing radiation rather than excision with a blade. Like other forms of radiation therapy, it is usually used to treat cancer. Radiosurgery was originally defined by the Swedish neurosurgeon Lars Leksell as "a single high dose fraction of radiation, stereotactically directed to an intracranial region of interest".

Nordion Inc., a Sotera Health company, is a health science company that provides Cobalt-60 used for sterilization and treatment of disease (radiotherapy).

Harold Elford Johns was a Canadian medical physicist, noted for his extensive contributions to the use of ionizing radiation to treat cancer.

<span class="mw-page-title-main">Cobalt-60</span> Radioactive isotope of cobalt

Cobalt-60 (60Co) is a synthetic radioactive isotope of cobalt with a half-life of 5.2713 years. It is produced artificially in nuclear reactors. Deliberate industrial production depends on neutron activation of bulk samples of the monoisotopic and mononuclidic cobalt isotope 59
Co
. Measurable quantities are also produced as a by-product of typical nuclear power plant operation and may be detected externally when leaks occur. In the latter case the incidentally produced 60
Co
is largely the result of multiple stages of neutron activation of iron isotopes in the reactor's steel structures via the creation of its 59
Co
precursor. The simplest case of the latter would result from the activation of 58
Fe
. 60
Co
undergoes beta decay to the stable isotope nickel-60. The activated nickel nucleus emits two gamma rays with energies of 1.17 and 1.33 MeV, hence the overall equation of the nuclear reaction is:

Radionuclides which emit gamma radiation are valuable in a range of different industrial, scientific and medical technologies. This article lists some common gamma-emitting radionuclides of technological importance, and their properties.

<span class="mw-page-title-main">Fast neutron therapy</span>

Fast neutron therapy utilizes high energy neutrons typically between 50 and 70 MeV to treat cancer. Most fast neutron therapy beams are produced by reactors, cyclotrons (d+Be) and linear accelerators. Neutron therapy is currently available in Germany, Russia, South Africa and the United States. In the United States, one treatment center is operational, in Seattle, Washington. The Seattle center uses a cyclotron which produces a proton beam impinging upon a beryllium target.

Intraoperative radiation therapy (IORT) is radiation therapy that is administered during surgery directly in the operating room.

Particle therapy is a form of external beam radiotherapy using beams of energetic neutrons, protons, or other heavier positive ions for cancer treatment. The most common type of particle therapy as of August 2021 is proton therapy.

Radiobiology is a field of clinical and basic medical sciences that involves the study of the action of ionizing radiation on living things, especially health effects of radiation. Ionizing radiation is generally harmful and potentially lethal to living things but can have health benefits in radiation therapy for the treatment of cancer and thyrotoxicosis. Its most common impact is the induction of cancer with a latent period of years or decades after exposure. High doses can cause visually dramatic radiation burns, and/or rapid fatality through acute radiation syndrome. Controlled doses are used for medical imaging and radiotherapy.

Intraoperative electron radiation therapy is the application of electron radiation directly to the residual tumor or tumor bed during cancer surgery. Electron beams are useful for intraoperative radiation treatment because, depending on the electron energy, the dose falls off rapidly behind the target site, therefore sparing underlying healthy tissue.

<span class="mw-page-title-main">Alpha particle</span> Helium-4 nucleus; particle of two protons and two neutrons

Alpha particles, also called alpha rays or alpha radiation, consist of two protons and two neutrons bound together into a particle identical to a helium-4 nucleus. They are generally produced in the process of alpha decay, but may also be produced in other ways. Alpha particles are named after the first letter in the Greek alphabet, α. The symbol for the alpha particle is α or α2+. Because they are identical to helium nuclei, they are also sometimes written as He2+
or 4
2
He2+
indicating a helium ion with a +2 charge. Once the ion gains electrons from its environment, the alpha particle becomes a normal helium atom 4
2
He
.

The history of radiation therapy or radiotherapy can be traced back to experiments made soon after the discovery of X-rays (1895), when it was shown that exposure to radiation produced cutaneous burns. Influenced by electrotherapy and escharotics — the medical application of caustic substances — doctors began using radiation to treat growths and lesions produced by diseases such as lupus, basal cell carcinoma, and epithelioma. Radiation was generally believed to have bactericidal properties, so when radium was discovered, in addition to treatments similar to those used with x-rays, it was also used as an additive to medical treatments for diseases such as tuberculosis where there were resistant bacilli.

<span class="mw-page-title-main">Neutron capture therapy of cancer</span> Nonsurgical therapeutic modality for treating locally invasive malignant tumors

Neutron capture therapy (NCT) is a type of radiotherapy for treating locally invasive malignant tumors such as primary brain tumors, recurrent cancers of the head and neck region, and cutaneous and extracutaneous melanomas. It is a two-step process: first, the patient is injected with a tumor-localizing drug containing the stable isotope boron-10 (10B), which has a high propensity to capture low energy "thermal" neutrons. The neutron cross section of 10B is 1,000 times more than that of other elements, such as nitrogen, hydrogen, or oxygen, that occur in tissue. In the second step, the patient is radiated with epithermal neutrons, the sources of which in the past have been nuclear reactors and now are accelerators that produce higher energy epithermal neutrons. After losing energy as they penetrate tissue, the resultant low energy "thermal" neutrons are captured by the 10B atoms. The resulting decay reaction yields high-energy alpha particles that kill the cancer cells that have taken up enough 10B.

A radiotherapy accident in Columbus, Ohio, also known as the Riverside radiation case, occurred as the result of an incorrectly calibrated cobalt teletherapy unit, occurred between 1974 and 1976, leading to 10 deaths.

References

  1. "Science: Radium". Time . 9 August 1937. ISSN   0040-781X. OCLC   1311479. Archived from the original on 22 June 2022. Retrieved 22 June 2022. Present price of radium is $25 per milligram, $25,000 per gram, $700,000 per ounce.
  2. "Cobalt-60: Explore our legacy of nuclear medicine innovation". University of Saskatchewan . n.d. Archived from the original on 8 March 2022. Retrieved 22 June 2022. In 1951, University of Saskatchewan medical physicist Dr. Harold Johns and his graduate students became the first researchers in the world to successfully treat a cancer patient using cobalt-60 radiation therapy. This innovative technology—dubbed the "cobalt bomb" by the media—revolutionized cancer treatment and saved the lives of millions of cancer patients around the world.
  3. "Cultural Heritage Assessment: Buildings in the South Street Hospital Complex, London, Ontario" (PDF). p. 46. Archived (PDF) from the original on 4 May 2020. Retrieved 3 May 2020. It is perhaps fitting, given the symbolic emphasis that the War Memorial Children's Hospital placed on turning the spoils of war to the benefits of peace, that this facility became the first place in the world to use the Cobalt-60 Beam Therapy Unit (the Cobalt Bomb) in the treatment of a Cancer patient, on October 27, 1951.
  4. "Celebrating the 60th anniversary of the world's first cancer treatment with Cobalt-60 radiation". London Health Sciences Centre . 27 October 2011. Archived from the original on 27 April 2022. Retrieved 23 June 2022. On October 27, 1951, the world's first cancer treatment with Cobalt-60 radiation took place at Victoria Hospital. This marked an important milestone for both the fight against cancer and Canada's emergence as a leader in the field of radiotherapy. Today, London Health Sciences Centre is pleased to acknowledge the 60th anniversary of this tremendous medical breakthrough.
  5. ""New Era" In Cobalt Treatment Of Cancer". The Sydney Morning Herald . No. 29649 (Late ed.). 1 November 1961. p. 14. ISSN   0312-6315. LCCN   sn84035933. OCLC   226369741. Archived from the original on 28 May 2022. Retrieved 23 June 2022 via Google News.
  6. Markel, Howard (17 December 2018). "How a strange rumor of Walt Disney's death became legend". Health. PBS NewsHour . Archived from the original on 18 June 2022. Retrieved 23 June 2022. The always energetic man struggled to go back to the Disney studios after the operation, but the chemotherapy and cobalt X-ray treatments drained him of both his creative and physical powers. He was rushed back to St. Joseph's Hospital two weeks later and died of "circulatory collapse" on the morning of Dec. 15.
  7. "Nuclear Medicine Dedication At Cedars Hospital". National Library of Israel. B'nai B'rith Messenger, January 11 1963. Retrieved 13 July 2022.
  8. Eckerman, K.; Endo, A. (2008). "Annex A. Radionuclides of the ICRP-07 collection". Annals of the ICRP | Nuclear Decay Data for Dosimetric Calculations. ICRP Publication 107. Vol. 38. International Commission on Radiological Protection. pp. 35–96. doi: 10.1016/j.icrp.2008.10.002 . ISBN   978-0-7020-3475-6. ISSN   0146-6453. LCCN   78647961. PMID   19285593.